Idiopathic pneumonia syndrome Cryptogenic organizing pneumonia Hematopoietic cell transplantation Idiopathic pneumonia syndrome (IPS) is an uncommon but deadly complication of transplantation with many clinical phenotypes. A better understanding of IPS pathobiology and the role of occult infection is needed to develop effective therapies. Some drugs given for conditioning or graft-versus-host disease prevention and treatment have known potential pulmonary toxicities. Venous thromboembolism and pulmonary hypertension can cause pulmonary symptoms with normal chest imaging after a hematopoietic cell transplant. proteinosis, venous thromboembolism, and pulmonary hypertension. 